• Login
    View Item 
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    Correlates of Labeling Changes and Serious Safety Outcomes for New Molecular Entities (NMEs) Approved by the Food and Drug Administration (FDA)

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Pinnow_umaryland_0373D_10794.pdf
    Size:
    3.426Mb
    Format:
    PDF
    Download
    Author
    Pinnow, Ellen E.
    Advisor
    Amr, Sania
    Date
    2016
    Type
    dissertation
    
    Metadata
    Show full item record
    Abstract
    The Food and Drug Administration (FDA) monitors safety profiles of drugs through premarket evaluation and approval and continued postmarket surveillance; the latter aims to identify new drug safety outcomes not detected in premarket clinical trials, and to communicate the risks to healthcare providers and consumers through changes to the drug's label. Investigations of premarket characteristics, such drug review and approval times, approval pathways (e.g. priority review, breakthrough designation, fast track designation, and accelerated approval), and the use of a surrogate endpoint in the clinical trial, and their potential associations with postmarket safety outcomes can assist FDA in designing and implementing an effective postmarket safety program. We evaluated the associations between premarket product information and review characteristics and postmarket safety-related outcomes (label changes, withdrawals) and their timing for New Molecular Entities (NMEs). We assessed NMEs approved by the FDA between 10/1/2002 and 12/31/2014, and the resulting safety-related outcomes through 12/31/2015, by estimating odds ratios (OR), hazard ratios (HR) and 95% confidence interval (CI). A cohort of 278 approved NME drugs was followed from 377 to 4815 days. Safety outcomes were identified in 202 (72.7%) drugs; and of those 35 had at least one serious postmarket safety outcome (one withdrawn and 34 receiving an additional warning). We found that safety-related label changes occur throughout a drug's lifespan. An increase of any postmarket safety outcomes, albeit not statistically significant, was seen in fast track NMEs (Adjusted OR =1.53, 95% CI 0.72, 3.24) but not in other review pathways. NMEs with accelerated approval, composed primarily of drugs approved using a surrogate endpoint also had an increase in any postmarket safety outcomes (HR =1.58; 95% CI 1.01, 2.49). Small significant differences were seen for NMEs with shorter review time; a 10 day decrease in approval time was associated with a 3% increase in risk of safety outcomes only for drugs with priority review. The association of shorter review time with postmarket safety outcomes among NME drugs indicates the importance of continued rigorous monitoring for approved priority drugs once they are made available to the public.
    Description
    University of Maryland, Baltimore. Epidemiology and Preventive Medicine. Ph.D. 2016
    Keyword
    postmarket drug safety
    Pharmacovigilance
    Identifier to cite or link to this item
    http://hdl.handle.net/10713/6293
    Collections
    Theses and Dissertations All Schools
    Theses and Dissertations School of Medicine

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.